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Abstract 
Background 
Over 50,000 non-medical healthcare professionals across the United Kingdom now have 
prescribing capabilities. However, there is no evidence available with regards to the extent to 
which non-medical prescribing (NMP) has been implemented within organisations across a 
strategic health authority (SHA). The aim of the study was to provide an overview of NMP 
across one SHA. 
Methods 
NMP leads across one SHA were asked to supply the email addresses of NMPs within their 
organisation. One thousand five hundred and eighty five NMPs were contacted and invited to 
complete an on-line descriptive questionnaire survey, 883 (55.7%) participants responded. 
Data was collected between November 2010 and February 2011. 
Results 
The majority of NMPs were based in primary care and worked in a team of 2 or more. Nurse 
independent supplementary prescribers were the largest group (590 or 68.6%) compared to 
community practitioner prescribers (198 or 22.4%), pharmacist independent supplementary 
prescribers (35 or 4%), and allied health professionals and optometrist independent and/or 
supplementary prescribers (8 or 0.9%). Nearly all (over 90%) of nurse independent 
supplementary prescribers prescribed medicines. Approximately a third of pharmacist 
independent supplementary prescribers, allied health professionals, and community 
practitioner prescribers did not prescribe. Clinical governance procedures were largely in 
place, although fewer procedures were reported by community practitioner prescribers. 
General practice nurses prescribed the most items. Factors affecting prescribing practice 
were: employer, the level of experience prior to becoming a non-medical prescriber, 
existence of governance procedures and support for the prescribing role (p < 0.001). 
Conclusion 
NMP in this strategic health authority reflects national development of this relatively new 
role in that the majority of non-medical prescribers were nurses based in primary care, with 
fewer pharmacist and allied health professional prescribers. This workforce is contributing to 
medicines management activities in a range of care settings. If non-medical prescibers are to 
maximise their contribution, robust governance and support from healthcare organisations is 
essential. The continued use of supplementary prescribing is questionable if maximum 
efficiency is sought. These are important points that need to be considered by those 
responsible for developing non-medical prescribing in the United Kingdom and other 
countries around the world. 
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Background 
Increasing socioeconomic and political demands on United Kingdom (UK) healthcare 
systems have seen the extension of prescribing rights to groups of non-medical healthcare 
professionals. Enhancing the role of these healthcare professionals to include prescribing is 
fundamental to improvements in the quality and accessibility of healthcare [1]. Although 
several countries (e.g. Australia, Ireland, and the United States), have implemented 
prescribing by non-medical healthcare professionals and, it is planned for in others (for 
example the Netherlands) [2,3], no other country has such extended non-medical prescribing 
(NMP) rights as the UK. 
Community nurse practitioners in the UK were the first group to be provided with the 
capacity to prescribe, and these community practitioner prescribers are able to independently 
prescribe from a limited list of medicines and conditions (including minor ailments and 
wound dressings), listed in the Nurse Prescribers Formulary for Community Practitioners [4]. 
Independent prescribing rights were extended in 2001 to include other groups of registered 
nurses [5]. Nurse independent supplementary prescribers (NISPs) are able to independently 
prescribe any medicine (including controlled drugs and unlicensed medicines) [6] and can 
also prescribe any medicine as a supplementary prescriber [1]. Supplementary prescribing, 
which takes place after assessment and diagnosis of a patient’s condition by a doctor, 
involves the development of a Clinical Management Plan (agreed by the patient, doctor and 
supplementary prescriber) which outlines the list of medicines from which the supplementary 
prescriber is able to prescribe for a patient [5]. 
Pharmacists were given supplementary prescribing rights in 2003 and later legislative 
changes also enabled this group the same independent prescribing rights as nurses [7]. More 
recently optometrists, and allied health professionals (AHPs) (i.e. physiotherapists, 
radiographers, and chiropodists/podiatrists) have been able to train as supplementary 
prescribers and optometrists are now able to prescribe independently [8]. Training to become 
a NMP prescriber typically involves 27 days in the classroom and 12 days in practice under 
the supervision of a doctor [4]. 
There are approximately 33,000 community practitioner prescribers, 23,000 NISPs, 2000 
pharmacist independent supplementary prescribers (PISPs), and several hundred AHPs and 
optometrist, working across the UK, with prescribing capability [9]. This represents between 
1% to 3% of the current nursing, pharmacy, AHPs and optometrist workforce [10]. The 
numbers are set to rise with the extension of prescribing rights to other non-medical 
healthcare professional groups [11]. 
Stakeholders are generally satisfied with NMP [12-15] and report that it increases the 
accessibility and flexibility of services [16,17]. A number of benefits for NMPs themselves 
have also been reported including greater autonomy and increased job satisfaction, more time 
with patients and the ability to provide a complete episode of care, increased self-confidence, 
and time savings [18-21]. There are however, wide variations in the numbers of prescribers 
both within and across organisations [22] and barriers to NMP have been reported including 
restrictions of local arrangements (such as inability to access prescription pads), inability to 
computer generate prescriptions, lack of peer support, organisational and policy restrictions, 
and difficulties in fulfilling continuing professional development needs [23]. Inconsistencies 
in the clinical governance systems within which NMPs work have also been identified [15] 
and such inconsistencies can influence prescribing activity and its on-going use. 
The profile and prescribing practices of NISPs [23] and the prescribing activity of nurse and 
pharmacist independent prescribers [24] have been explored in two national surveys. 
Additionally, a number of small studies have explored the impact and effectiveness of 
community practitioner prescribers [25]. However, there is no evidence available with 
regards to the extent to which NMP (including community practitioner prescribers, nurse, 
pharmacist and AHP independent/supplementary prescribers) has been implemented within 
healthcare organisations across a large geographical area. At the time of the study, the 
National Health Services (NHS) in England was divided into 10 areas and managed by 
strategic health authorities (SHAs). Each SHA had the responsibility to manage the local 
NHS across large geographical areas that encompass numerous health care organisations 
(including primary care trusts (PCTs), acute trusts, mental health trusts and general 
practices). The aim of the study was to provide an overview of NMP across one SHA. The 
specific objectives were to identify: 
1) The non-medical healthcare professionals qualified to prescribe medicines i.e. their job 
title, the care setting in which they worked, and their clinical experience and 
qualifications 
2) The mode of prescribing used by these healthcare professionals, the frequency with 
which they prescribe, and the different ways in which the prescribing qualification is 
used 
3) The safety and clinical governance systems within which these healthcare professionals 
work 
Methods 
Design 
An on-line descriptive questionnaire survey 
Participants 
Eight hundred and eighty three NMPs within one SHA 
Questionnaire 
SurveyMonkey—a tool for creating web surveys—was used to develop an on-line 
questionnaire (see Additional file 1). The questionnaire, informed by previous work 
undertaken by the researchers [15,23,26], was divided into 4 sections. Questions were mainly 
fixed choice with room for open ended comment. Section 1 collected general demographic 
information including job title, county in which the participant worked, employer, highest 
academic qualification, care setting and number of NMPs in the team. Section 2 asked 
questions specific to participants prescribing background including prescribing qualification 
held, number of years qualified as a prescriber, number of years’ experience in main area of 
prescribing practice prior to undertaking the prescribing programme, specialist training prior 
to becoming a prescriber. Section 3 comprised questions about prescribing practice. 
Questions included the method of prescribing currently used and the number of items 
prescribed, the different ways in which the prescribing qualification was used (i.e. 
participants were asked to indicate from a list of 12 statements the methods they used/did not 
use), and the therapy areas in which participants prescribed. The final section focused on 
clinical governance. Participants were asked to indicate from a list of 11 statements their 
experience of the clinical governance systems in place within their organisation. Participants 
were also asked whether or not they had received support from their NMP lead. 
Data collection 
Guidance [1] refers to the responsibilities of NHS organisations to develop a strategic plan 
for NMP. This plan includes the appointment of an NMP lead responsible for the 
implementation of NMP within an organisation. As part of safety and clinical governance 
arrangements, the NMP lead is responsible for the maintenance of a current database 
containing the details of NMPs within their organisation. Information supplied by the SHA, 
identified that 45 NMP leads were designated as responsible for NMPs within the 50 trusts 
across the 6 counties (Suffolk, Essex, Cambridgeshire, Norfolk, Hertfordshire, Bedfordshire) 
comprising the East of England (EoE) SHA (see Figure 1). Each of these leads were 
contacted by the researchers and asked if they would supply the email addresses of all NMPs 
listed on their database. In order to comply with SHA policy and the Data Protection Act 
(1998), an NHS laptop and an NHS email address was used for all email communication 
between a researcher (NC), NMP leads and NMPs. 
Figure 1 Number of Trusts across the Strategic Health Authority who provided email 
contact list 
Forty leads, responsible for 44 trusts, responded. Although 38 were able to provide a current 
electronic database of NMPs, two were unable to do so. These two leads emailed the NMPs 
for whom they were responsible, and requested that they made contact with the researchers in 
order to participate in the survey. 
Two thousand and nine NMPs (comprising community practitioner prescibers, NISPs, PISPs, 
optometrists independent/supplementary prescribers, and AHP supplementary prescribers) 
were identified, of whom 1,869 had email addresses. An email containing an invitation letter, 
outlining the purpose of the study, and the link to the on-line questionnaire was sent to each 
NMP with an email address. Delivery receipts were requested. One thousand five hundred 
and eighty five emails were acknowledged as delivered. Participants were sent three follow-
up reminder emails. Data collection took place between November 2010 and February 2011. 
Ethical consideration 
Ethical approval for the study was provided by the University of Surrey. The study was 
deemed a service evaluation by Cambridgeshire 4 Research Ethics Committee. 
Data analysis 
Microsoft Excel and SPSS version 17 were used for data entry and analysis. Descriptive 
statistics were used to describe the demographic nature of the sample. Analysis of variance 
(ANOVA) was used to explore whether the number of items prescribed differed according to 
individual demographic variables such as job title, employer, care setting, and time since 
qualifying as prescriber. General linear modelling (GLM), a popular generalisation of the 
linear regression model [27], was also used to explore whether demographic variables (i.e. 
job title, employer, care setting, and time since qualifying as prescriber) contributed 
significantly to explaining the variation in the ways the prescribing qualification was used, 
and the extent to which clinical governance procedures were in place. Chi-square was used to 
explore the difference between demographic variables and the level of support received 
before, during and after the prescribing programme. Content analysis was used to analyse 
free text comments. 
Results 
Of the 1,585 participants invited to complete the survey, 883 (55.7%) participants responded. 
Demographic information 
The demographic data of the sample are presented in Table 1. Participants were from all six 
counties across the SHA, with 307 (34.8%) based in Essex. Of those who reported their job 
title, 826 (94.8%) respondents were nurses, the largest majority (n = 254 or 28.8%) of whom 
had specialist roles. Thirty six (4.1%) respondents were pharmacists, 9 (1.0%) were AHPs 
and this included one optometrist. The majority of nurses (n = 391, 47.3%) were employed by 
PCTs (including community trusts and provider services) whereas a higher percentage of 
pharmacists (n = 24, 68.6%) and AHPs (n = 7, 77.8%) were employed by acute trusts (see 
Figure 2). Degrees or higher degrees were held by 632 (71.5%) participants (see Table 1). 
The number of NMPs per team ranged from one (n = 278, 31%) to over 10 (n = 37, 4.3%) 
(mean =5.48, median = 2.0). Just over a third (n = 299, 33.9%) of respondents indicated that 
there were plans to increase these numbers. 
Table 1 Demographic Details 
 n=number of 
responses 
% of total 
sample 
Job Title  
Specialist nurses (clinical nurse specialists, specialist nurse practitioners, nurse 
clinician, paediatric specialist nurse) 
254 28.8 
Community Nurses (community matron, children’s community nurse, health 
visitor, district nurse, school nurse) 
201 22.8 
General practice nurses (practice nurses and nurse practitioners) 150 17.0 
Senior clinical nurses ( nurse consultant, lead nurse, ward manager, sister, 
charge nurse, team leader, modern matron) 
120 13.6 
Mental Health Nurses( community psychiatric nurse, primary care link worker, 
liaison nurse, clinical co-ordinator) 
54 6.1 
Pharmacists (team leader/manager, senior clinical pharmacist, senior 
pharmacist (care homes, elderly, transplant), education and training pharmacist, 
community pharmacist, practice support pharmacist) 
36 4.1 
Nurse Managers (Director of nursing, service lead, information manager) 33 3.7 
Allied Health Professionals (clinical specialist physiotherapist (chronic pain, 
elderly), podiatric diabetes specialist, clinic radiographer) & Optometrist 
9 1.0 
Others nurses (practice development, education, research) 14 1.6 
Geographical location  
Essex 307 34.8 
Norfolk 161 18.2 
Cambridgeshire 142 16.1 
Suffolk 119 13.5 
Hertfordshire 76 8.6 
Bedfordshire 65 7.4 
Employer  
Primary care Trust (incl community trust and other provider services) 406 46.0 
Acute Trust 276 31.3 
General Practice 112 12.7 
Mental Health 64 7.2 
Others (including prisons) 8 0.9 
Care setting  
Primary care (including intermediate care) 503 57.0 
Secondary Care (including tertiary care) 240 27.2 
Primary and Secondary Care 65 7.4 
Mental Health (including learning disabilities, & prisons) 53 6.0 
Prescribing qualification   
Nurse Independent Supplementary Prescriber(NISP) 590 66.8 
Community Practitioner Prescriber (CP) 198 22.4 
Pharmacist Independent Supplementary Prescriber & Pharmacist Supplementary 
Prescriber (PISP) 
35 4.0 
Other prescribing qualifications ( Physiotherapist, Podiatrist or Radiographer 
Supplementary Prescriber, Optometrist Independent Supplementary Prescriber) 
8 0.9 
Years qualified as a prescriber   
< 1 year 50 5.7 
1-3 years 257 29.1 
3-5 years 223 25.3 
> 5 years 287 32.5 
Experience in area of practice before becoming prescriber   
< 1 year 93 10.5 
1-2 years 43 4.9 
2-5 years 153 17.3 
> 5 years 522 59.1 
Highest level of educational attainment   
Certificate 62 7.0 
Diploma 156 17.7 
Degree 441 49.9 
Higher Degree (Masters or PhD) 191 21.6 
Level of specialist training before prescribing programme   
Diploma module 74 8.4 
Degree module 156 17.7 
Masters module 44 5.0 
Degree and/or masters module plus study days & / or other training 241 27.3 
Accredited study days & other training (e.g. conference/drug company) 76 8.6 
No specialist training 216 24.5 
Percents do not add to 100% in each category as some participants did not complete every 
question 
Figure 2 Profession and Employer 
Prescribing background 
Five hundred and ninety (66.8%) participants reported they were NISPs, nearly a quarter (n = 
198, 22.4%) were community practitioners, with only small numbers (n = 43, 4.9%) of 
pharmacists, AHPs, or optometrist independent and/or supplementary prescribers (see Table 
1). The majority of participants (n = 510, 57.8%) had been qualified to prescribe for more 
than three years and 675 (76.4%) indicated that they had more than two years’ experience in 
their area of practice before undertaking the prescribing programme. Four hundred and forty 
one (50%) reported they had undertaken degree and / or masters level specialist training in 
their area of prescribing practice. 
Prescribing practice 
Five hundred and seventy eight (65.5%) participants reported that they currently used 
independent prescribing and 28 (3.2%) that they only used supplementary prescribing. A 
further 58 (6.6%) reported that they used both independent and supplementary prescribing. In 
addition to being ‘only qualified as a supplementary prescriber (n = 39) the most frequently 
cited reasons for using supplementary prescribing were ‘trust policy’ (n = 39), ‘personal 
preference’ (n = 26 ) and ‘controlled drug restrictions’ (n = 24 ) (Legislation restricting 
independent prescribing of controlled drugs by nurses and pharmacists was amended 
following data collection in this study [6]. 
One hundred and thirty three (15.1%) participants reported they did not currently prescribe. 
This included 59 (29.7%) of those who reported they had the community practitioner 
prescribing qualification, 56 (9.5%) of NISPs, 13 (37.1%) of PISPs and three (37.5%) AHPs 
(including an optometrist). Reasons for not prescribing identified from free text comments 
included role change (n = 56), procedural delays (e.g. lack of electronic prescribing and 
access to patient notes) (n = 27), formulary restrictions or trust policy (n = 26), a lack of 
support from employers and managers and lack of continuing professional development (n = 
16). Community practitioners more often reported procedural delays (n = 23) and were the 
only group to mention a lack of continuing professional development and confidence as a 
reason for not prescribing. AHPs (n = 3) reported restrictions in the applicability of 
supplementary prescribing as the main reason for not prescribing. 
Participants (n = 672, 76.1%) reported using independent prescribing to prescribe a mean 
number of 16.4 items per week and 254 (28.9%) reported using supplementary prescribing to 
prescribe a mean number of 5.7 items per week (see Table 2). 
Table 2 Number of items prescribed by using independent and supplementary 
prescribing in a typical week 
Number of items per week Independent Prescribing Supplementary Prescribing 
0 69 (10.3%) 170 (66.9%) 
1-5 219 (32.6%) 53(20.9%) 
6-10 120(17.9%) 16 (6.3%) 
11-20 85(12.6%) 8 (3.1%) 
21-30 59 (8.8%) 4 (1.6%) 
31-40 27 (4.0%) 1(0.4%) 
41-50 24 (3.6%) 0 (0.0%) 
>50 69 (10.3%) 2 (0.8%) 
Total number of respondents 672 (100%) 254 (100%) 
Table 3 The extent to which to safety and clinical governance systems are in place 
n=number of respondents who answered the question Yes No 
 n % n % 
1. I have provided my employer with a specimen signature (n = 759) 694 91.4 65 8.6 
2. My employer provides me with each edition of the BNF/ the NPF for 
Community Practitioners (n = 714) 
655 91.2 59 8.6 
3. My employer ensures that I receive all relevant clinical information e.g. 
Patient Safety Notices, Drug Alerts and Hazard Warnings? (n = 758) 
678 89.5 80 10.5 
4. My employer has an up-to-date NMP policy (n = 740) 655 88.5 85 11.5 
5. My scope of practice has been agreed with my employer (n = 754) 642 85.1 112 14.9 
6. I know how to contact my NMP lead (n = 754) 629 83.4 125 16.6 
7. I have access to CPD to support me in prescribing role (via 
employer/trust/independently) (n = 755) 
561 74.3 194 25.7 
8. I am involved with regular clinical audit and review of my clinical services 
(n = 750) 
480 64.0 270 26.0 
9. My employer has involved me in the development of local formularies and 
guidelines (n = 755) 
358 47.7 397 52.6 
10. My employer provides me with regular data to monitor my prescribing 
practice (n = 751) 
328 43.7 423 16.3 
11. I am able to access my own prescribing data (via PACT or otherwise) (n = 
746) 
281 37.3 465 62.3 
(NMP=non medical prescribing, BNF=British National Formulary, NPF=Nurse Prescribers 
Formulary, PACT=Prescription analysis and cost trend, CPD=continuing professional 
development) 
Using ANOVA it was evident that the number of items prescribed using independent 
prescribing was affected by the prescribing qualification. The mean number of items 
independently prescribed by NISPs (n = 484, mean =18.7), was significantly higher than 
PISPs, (n = 18, mean =12), or CPs, (n = 111, mean =7.2) (p < 0.001). 
Additional analysis using ANOVA identified the number of items prescribed using 
independent prescribing was also significantly affected by job title, employer, care setting 
and time since qualifying (p < 0.001). General practice nurses, those employed in general 
practice, participants working across primary and secondary care and those with more than 5 
years’ experience prior to undertaking the prescribing programme prescribed the greatest 
number of items each week. Those employed in general practice prescribed the greatest 
number of items per week (n = 103, mean = 38.9) and those employed by mental health trusts 
prescribed the lowest (n = 10, mean = 5.0). 
Prescribing qualification, job title, employer, care setting and time since qualifying were not 
found to have any significant effect on the number of items prescribed using SP (p > 0.05). 
Therapy areas 
The range of therapy areas for which participants prescribed are shown in Figure 3. Areas 
where the greatest number of NISPs prescribed were pain (239, 40.5%), minor ailments (n = 
224, 40.0%) and respiratory (n = 210, 35.6%). Community practitioners prescribed most 
often for dermatology (n = 70, 35.5%), minor ailments (n = 66, 33.3%) and wound care (n = 
55, 27.8%). In addition to minor ailments (n = 8, 22.9%), renal (n = 7, 20.0%) and respiratory 
(n = 6, 17.1%) were also therapy areas in which more PISPs prescribed. 
Figure 3 Therapy areas which NMPs prescribe 
Ways in which the prescribing qualification is used 
Participants reported that they used the prescribing qualification in a variety of ways (see 
Figure 4). The most common method cited was to make recommendations for patients to buy 
medicine(s) over the counter (n = 610, 80.6%). Over two thirds of community practitioners (n 
= 136, 68.7%) reported that they used it in this way. The most common method reported by 
NISPs (n = 458, 77.6%), and PISPs (n = 22, 62.9%) was to amend prescribed medication. 
Medication review was also reported to be conducted by a similar number of PISPs (n = 22, 
62.9%) (see Figure 5). 
Figure 4 Methods of using the prescribing qualification 
Figure 5 Methods of prescribing and prescribing qualification 
Using GLM it was evident that the number of ways the prescribing qualification was used 
was significantly affected by job title, employer, and care setting (p < 0.001). For example, a 
significantly greater number of general practice nurses, those employed in general practice, 
participants working in secondary care and those with more experience prior to undertaking 
the prescribing programme reported that they used the prescribing qualification in 6 or more 
ways (p < 0.001). 
Of the community practitioners (n = 59) who reported they did not prescribe, 54% (n = 32) 
recommended over-the-counter (OTC) medicines to patients, and 42% (n = 25) recommended 
medications for general practitioners to prescribe for patients. 
Safety and clinical governance systems 
Table 3 provides a summary of the extent to which participants reported that safety and 
clinical governance systems were in place. Over 90% of respondents reported that they had 
provided their employer with a specimen signature and received each edition of the British 
National Formulary (and/ or the Nurse Prescribers Formulary for Community Practitioners). 
Only 328 (43.7%) reported that their employer provided them with regular data to monitor 
their prescribing practice, and only 281 (37.3%) were able to access their own prescribing 
data. 
Figure 6 The extent to which to safety and clinical governance systems are in place and 
job title 
Using GLM it was evident that the extent to which safety and clinical governance systems 
were in place was significantly affected by job title, employer, and care setting, and 
prescribing qualification. For example, a significantly greater number of specialist nurses, 
those employed in acute trusts, participants working in mental health and those with the NISP 
qualification reported 6 or more clinical governance systems were in place (p < 0.001). 
Significantly fewer clinical governance systems were reported by community nurses and 
those with the community practitioner qualification (see Figure 7). 
Figure 7 Support received from the non-medical prescribing lead on an individual basis 
Support from NMP lead 
The level of support participants received from their NMP lead before, during and after the 
prescribing programme is shown in Figure 7. A greater number of respondents (n = 304, 
47.8%) reported that they received support after they had completed the prescribing 
programme. Using chi-square analysis it was evident that NISPs, those who worked in mental 
health, or had been qualified for less than a year received significantly greater levels of 
support at each of these three stages (p < 0.001). Significantly fewer community nurses, 
pharmacists, those employed by PCTs, primary care, and those qualified for more than 5 
years reported that they had received any support from their NMP lead (p < 0.001). 
Discussion 
This is the first study of NMP within one SHA which provides detailed information about the 
numbers and types of NMPs, their prescribing practice and clinical governance arrangements. 
It therefore provides an important overview of the development of NMP across a large 
geographical area of England. 
There are some limitations with the data set, in that email addresses of NMPs were not 
provided by NMP leads representing employees of six PCTs (including community trusts and 
other provider services). We therefore acknowledge an under-representation of NMPs 
employed by PCTs, particularly in Hertfordshire and Bedfordshire. The ratio of NISPs to 
PISPS, AHPs and optometrists in our sample reflects national data on NMP [9]. The high 
numbers of NISPs is unsurprising given the large nursing workforce in England, plus the fact 
that prescribing rights were granted to nurses first. Our response rate is 2% lower than a 
recent national evaluation of nurse and pharmacist independent prescribing [24]. Given the 
similar demographic profile of our sample to previous national evaluations of NMPs [23,24], 
we are confident that our findings present an accurate picture of this population. However, 
the proportion of community practitioner prescribers in our sample is lower than expected 
and is probably due to shortfalls in data provided by PCTs. While there have been national 
surveys of NISPs and PIPs, there is a lack of similar data on community practitioners with 
which to compare. It should also be noted that the data is self-report data, and therefore 
information such as items prescribed per week, are likely to be an estimate. 
Demographic profile 
In-line with previous national evidence [23,24,28], the majority of NMPs in this SHA were 
employed by PCTs and based in primary care. This reflects the organisation of the NHS in 
England and recent policy drives to provide care closer to home through services provided in 
the community [29]. Two thirds of PISPs were employed in secondary care; this is higher 
than reported by previously [24] where 36% were in secondary care and 55% in general 
practice. Overall a third of NMPs worked in secondary care; which is similar to that reported 
previously [23,24,28]. This indicates that NMP is developing in line with policy intention that 
it would contribute to improving access and quality of care in a range of settings [1]. 
Overall, the level of education and experience that NMPs had was equivalent to previous 
surveys [23,24,28]. Guidance specifies that applicants for the NMP programme must have at 
least one year’s experience in the area in which they intend to prescribe [1]. Although around 
90% of our sample had this experience (and 59.1% had over 5 years’ experience), 10.5% did 
not. Importantly, those in our sample with more prior experience made greater use of the 
prescribing qualification and prescribed more frequently than those with lesser experience. 
This highlights that experience helps to maximise use of the NMP role. Similarly, while most 
respondents had undertaken specialist education in their area of practice prior to undertaking 
prescribing, 24.5% had not. It has been found that nurses who acquire prior specialist 
knowledge are more likely to report that the prescribing course met their learning needs and 
prepared them to prescribe [30,31]. Patients have also been reported to have greater 
confidence in nurses who have more experience and specialist knowledge in their area of 
practice [32,33]. This reinforces the need to ensure that those selected for prescribing training 
have acquired the necessary specialist knowledge and experience [4]. 
Prescribing patterns 
A lack of prescribing activity is considered wasteful in terms of the time and expenses 
incurred for training [34] and failure to deliver predicted service improvement. Therefore, it 
is important to understand why some qualified NMPs do not prescribe. Although over 90% of 
NISPs reported that they currently prescribed medicines, approximately a third of PISPS, 
AHPs, and community practitioner prescribers, indicated that they did not. Prescribing rates 
amongst different groups have varied considerably since NMP was first introduced, for 
example, district nurses prescribe more frequently than health visitors [35], and NISPs [36], 
more frequently than community practitioner prescribers [37], mental health nurses [38], or 
pharmacists [24]. Among those NMPs who were currently prescribing, similar differences in 
prescribing patterns were found in this study, with lower rates reported by community 
practitioners prescribers, mental health nurses and PISPs. There are multiple factors, as well 
as differences in roles and practice settings, known to influence prescribing practice [39-41]. 
This study provides further insight into factors affecting this variation. 
The main reason given for not prescribing was that participants no longer worked in a role 
that required this activity. This provides some reassurance that some of the initial barriers to 
NMP (including restrictions at a local level such as lack of access to prescription pads and 
inability to generate electronic prescriptions) are now less problematic [23]. However, these 
problems continued to restrict use of the community practitioner prescribing qualification, 
perhaps reflecting the difficulty of accessing and using electronic patient records in general 
practice where different IT systems are in place. 
Of those who did prescribe, the rate of independent prescribing by nurses was similar to that 
reported in 2006 by nurse independent prescribers [23]. Nurses employed in general practice, 
however, prescribed significantly more items than those of other employers. In addition to 
prescribing more frequently, nurses in general practice, treating patients with diabetes [30] 
and dermatology [42], are known to prescribe for a greater range of conditions. This perhaps 
reflects the broad range of conditions encountered by these nurses and so the greater 
opportunity to prescribe. 
Prescribing rates were influenced by the level of support received from the NMP lead before, 
during and after prescribing training. Those with less support (i.e. PISPs and community 
practitioner prescribers) generally prescribed less frequently. Interestingly, the least number 
of items prescribed was by those employed by mental health nurses who actually received the 
highest level of support. This anomaly may indicate the presence of other factors that 
influence the rate of prescribing in mental health. A lack of support from clinicians, for 
example, has been cited [43] as a barrier to prescribing by this group however; further 
research exploring these barriers is required. Overall, levels of support were inconsistent, in-
line with previous study findings [15]. That those qualified for less than a year received more 
support perhaps indicates an increase in governance arrangements to provide support to NMP 
in recent times. 
Supplementary prescribing was used infrequently and mainly by a few participants confined 
to this mode of prescribing through their type of qualification, organisational policy, or 
restrictions on what medicines can be prescribing via independent prescribing. This 
contributes to growing national evidence on the low use of supplementary prescribing (23, 
44). Given that the main purpose of NMP was to maximise access and improve service 
efficiency, the continued usefullness of SP is questionable. This should be borne in mind by 
those involved in developing guidance on the extension of prescribing rights for other 
professionals. 
Ways of using the prescribing qualification 
Historically, the success of NMP has been measured by the numbers actively prescribing or 
the frequency of prescribing. While this is important, this is the first study to provide 
evidence that NMPs engage in a range of other activities that can also impact on service 
efficiency, quality of care and patient outcomes. Despite approximately a third of community 
practitioner prescribers and PISPs reporting they did not prescribe, 54% of the those 
community practitioners who were not prescribing recommended OTC medicines to patients, 
and 42% recommended medications for general practitioners to prescribe for patients. 
Furthermore, the majority of PISPS and NISPS amended prescribed medications, undertook 
medication reviews and made recommendations to general practitioners. Nurses employed in 
general practice and in acute trusts reported that they used the qualification in significantly 
more ways than other groups. An appreciation of these activities is necessary if NMPs are to 
be fully supported in their role. Further research designed to explore these activities is 
required if we are to fully understand the benefits (including cost benefits) of NMPs to 
service delivery. Crucially, if data on involvement in these medicines management activities 
is not captured then the true worth of NMP activity with respect to patient outcomes and the 
efficiency of care processes will not be recognised. This is of particular importance during 
the current economic climate and period of uncertainty regarding the re-organisation of the 
NHS. 
Governance issues 
For the most part, clinical governance arrangements were reported to be working, with the 
exception of the ability to obtain prescribing data and monitor or audit prescribing activity. 
These activities are important as they can provide a useful focus for clinical review, 
demonstrate evidence of safety and efficiency and highlight areas for continuing professional 
development. That fewer governance systems were in place for community practitioner 
prescribers may reflect the difficulties of maintaining procedures in community settings 
where lack of IT infrastructure can hamper communication and support for those working 
peripatetically. Poor infrastructure, lack of confidence, and poor access to continuing 
professional development were factors reported to prevent this group from prescribing. These 
findings, along with previous research on NMP governance [15], provide support for the need 
to further develop the clinical governance systems within which NMPs work. 
Conclusion 
NMP in this SHA reflects national development of this relatively new role in that the 
majority of NMPs are nurses based in primary care, with fewer pharmacist and AHP 
prescribers. In addition to prescribing, this workforce contributes to medicines management 
activities in a range of care settings. The extent, to which NMPs prescribed, was influenced 
by a number of factors including employer, the level of experience prior to becoming a NMP, 
and existence of governance procedures and support for the prescribing role. If NMPs are to 
maximise their contribution to patients and healthcare services robust governance and support 
from healthcare organisations is essential. This requirement will increase as the NMP 
workforce grows. The continued use of supplementary prescribing, which requires greater co-
working with a doctor and is used less frequently than independent prescribing, as a first step 
towards prescribing rights for health professionals is questionable if maximum efficiency is 
sought. These are important points that need to be considered by those responsible for 
developing NMP in the UK and other countries around the world. 
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Additional file 1 General Information. The questionnaire is aimed at non medical 
prescribers (NMPs). It should take you about 15 minutes to complete. Most questions require 
you to tick the box(s) that apply. If you make a mistake just tick the box you do require and it 
will change automatically. You can also scroll backward through the pages if you want to 
change a previous answer. Once you reach the end click on ‘finish’ and your answers will 
automatically be saved and sent to us. 
